Publications
2000-2004
2004
Integromic Analysis of the NCI-60 Cancer Cell Lines
Breast Dis. 2004;19:11-22.
Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistance.
Mol Pharmacol. 2004 Dec;66(6):1397-405. Epub 2004 Sep 01.
Is the Gene Expression Pattern of Lung Cancer Detected by Screening With Spiral Computed Tomography Different from That of Symptom-Detected Lung Cancer?
Clinical Cancer Research Vol. 10, 5973-5974, September 15, 2004
Predicting Drug Sensitivity and Resistance: Profiling ABC Transporter Genes in Cancer Cells
2004 Cell PressPII: Section: Cancer Cell, Vol 6, 129-137, August 2004
Membrane Transporters and Channels: Role of the Transportome in Cancer Chemosensitivity and Chemoresistance
Cancer Res. 2004 Jun 15;64(12):4294-301
Mistaken Identifiers: Gene name errors can be introduced inadvertently when using Excel in bioinformatics
BMC Bioinformatics 2004, 5:80 doi:10.1186/1471-2105-5-80
Apoptosis Defects and Chemotherapy Resistance: Molecular Interaction Maps and Networks
Oncogene. 2004 Apr 12;23(16):2934-49
Properties of Switch-like Bioregulatory Networks Studied by Simulation of the Hypoxia Response Control System
Mol Biol Cell. 2004 Jul;15(7):3042-52
Molecular Interaction Maps--A Diagrammatic Graphical Language for Bioregulatory Networks
Sci. STKE, Vol. 2004, Issue 222, pp. pe8
Cancer Drug Discovery: Genomics, Proteomics, and Bioinformatics
Molecular Target Therapy of Cancer, Vol. 1, in press
Linking Drugs and Genes: Pharmacogenomics, Pharmacoproteomics, Bioinformatics, and the NCI-60.
Oncogenomics: Molecular Approaches to Cancer. ISBN: 978-0-471-47664-1 Dec. 2004
2003
Karyotypic complexity of the NCI-60 drug-screening panel
Cancer Res. 2003 Dec 15;63(24):8634-47
Comparing cDNA and Oligonucleotide Array Data: Concordance of Gene Expression Across Platforms for the NCI-60 Cancer Cells
Genome Biol. 2003;4(12):R82
Proteomic Profiling of the NCI-60 Cancer Cell Lines Using New High-density Reverse-phase Lysate Microarrays
Proceedings of the National Academy of Science USA 2003 November 25th; 100(24): 14229-14234
Transcriptomic Analysis of the NCI-60 Cancer Cell Lines
C R Biol. 2003 Oct-Nov;326(10-11):909-20
Diagnostic Markers That Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling
Cancer Res 2003 Sep 1;63(17):5243-50
Apoptosis induced by topoisomerase inhibitors
Curr Med Chem Anti-Canc Agents. 2003 Jul;3(4):271-90.
Impact of p53-knockout and Topotecan Treatment on Gene Expression Profiles in Human Colon Carcinoma Cells: A Pharmacogenomics Study.
Cancer Res 2003 Jun 1;63(11):2782-93
Apoptotic Susceptibility of Cancer Cells Selected for Camptothecin Resistance: Gene Expression Profiling, Functional Analysis, and Molecular Interaction Mapping
Cancer Res 2003 Mar 1;63(5):1000-11
MatchMiner: A Tool for Batch Navigation among Gene and Gene Product Identifiers
Genome Biol, 4(4):R27
GoMiner: A Resource for Biological Interpretation of Genomic and Proteomic Data
Genome Biol, 4(4):R28
Cell cycle and checkpoints in oncology: new therapeutic targets
Med Sci (Paris). 2003 Feb;19(2):173-86
2002
Pharmacogenomic Analysis: Correlating Molecular Substructure Classes with Microarray Gene Expression Data
The Pharmacogenomics Journal (Nature) 2002; 2:259-271.
Transcriptional Regulation of Mitotic Genes by Camptothecin-Induced DNA Damage: Microarray Analysis of Dose- and Time-Dependent Effects
Cancer Res 2002 Mar 15;62(6):1688-95
The Bioinformatics of Microarray Gene Expression Profiling
Cytometry 2002 Jan 1;47(1):46-9
'Omic' and Hypothesis-driven Research in the Molecular Pharmacology of Cancer
Curr Opin Pharmacol 2002 Aug;2(4):361-5
2001
Chemosensitivity Prediction by Transcriptional Profiling.
Proc Natl Acad Sci U S A 2001 Sep 11;98(19):10787-92
The DNA-repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
New England J. Med. 344: 686 (2001)
Quantitative Structure-Antitumor Activity Relationships of Camptothecin Analogues: Cluster Analysis and Genetic Algorithm-Based Studies
J Med Chem 2001 Sep 27;44(20):3254-63
Comparison of a Neural Net-based QSAR Algorithm (PCANN) with Hologram- and Multiple Linear Regression-based QSAR Approaches: Application to 1,4-dihydropyridine-based Calcium Channel Antagonists
J Chem Inf Comput Sci 2001 May-Jun;41(3):505-11
Searching for Pharmacogenomic Markers: the Synergy Between Omic and Hypothesis-Driven Research
Dis Markers 2001;17(2):77-88
Molecular Interaction Maps as Information Organizers and Simulation Guides
Chaos. 2001 Mar;11(1):84-97
A Gene Expression Database for the Molecular Pharmacology of Cancer
Nature Genetics, volume 24, no 3 March 1st, 2000 pp:236-244
Systematic Variation in Gene Expression Patterns in Human Cancer Cell Lines
Nature Genetics, 2000 March, 24(3):227-234
EDGAR: Extraction of Drugs, Genes and Relations from the Biomedical Literature
Pacific Symposium on Biocomputing 5:514-525 (2000)
Mining and Visualizing Large Anticancer Drug Discovery Databases
J Chem Inf Comput Sci. 2000; 40:367-379
Pharmacogenomics: Teaching Old Drugs New Tricks
New England J. Med. 343: 1408-1409 (2000)
Combination Gene Therapy: Synergistic Inhibition of Human Immunodeficiency Virus Tat and Rev Functions by a Single RNA Molecule
Hum Gene Ther 2000 Apr 10;11(6):807-15
Molecular Targets in Cancer Drug Discovery: Cell-Based Profiling
Curr Pharm Des 2000 Mar;6(4):473-83